Skip to content
ChickenStockChickenStock
ResearchELV
Elevance Health logo

Elevance Health (ELV) stock

NYSE

$446.28+3.86%(+16.59)

As of the Nov 16, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

18.76x

P/B

2.16x

P/S

0.48x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 1.4% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 21, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

19 SEC filings
  • LAVU RATNAKAREVP & Chief Digital Info Ofr · Nov 5, 2026Open-market sale1,300 shares · $572K
    Avg. price $44014,849 shares held after
  • Kaye MarkEVP & CFO · Oct 22, 2026Open-market sale10,584 shares · $4.7M
    Avg. price $440.132
    Show 13 price lots
    • 2,343 shares × $441.34$1.0M
    • 1,720 shares × $440.44$758K
    • 1,660 shares × $436.2$724K
    • 1,160 shares × $439.25$510K
    • 827 shares × $446.05$369K
    • 560 shares × $437.07$245K
    • 480 shares × $442.61$212K
    • 440 shares × $443.81$195K
    • 400 shares × $434$174K
    • 321 shares × $435.25$140K
    • 273 shares × $447.19$122K
    • 240 shares × $438.22$105K
    • 160 shares × $444.85$71K
  • Kaye MarkEVP & CFO · Oct 2, 2026Shares withheld for taxes4,161 shares · $1.6M
    Avg. price $386.4327,876 shares held after
  • Kaye MarkEVP & CFO · Oct 2, 2026Grant or award2,627 shares · $0
    Avg. price $030,503 shares held after
  • Wessling Erin MEVP & Chief Legal Officer · Sep 3, 2026Shares withheld for taxes255 shares · $106K
    Avg. price $414.787,230 shares held after
  • Craig Ryan REVP & Chief HR Officer · Sep 2, 2026Shares withheld for taxes144 shares · $58K
    Avg. price $405.846,530 shares held after
  • Wessling Erin MEVP & Chief Legal Officer · Sep 2, 2026Shares withheld for taxes94 shares · $38K
    Avg. price $405.847,485 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Elevance Health (ELV) stock information

NYSE

Elevance Health (ELV) is listed on NYSE. Its market capitalization is about $96.4B. On trailing-twelve-month earnings the P/E ratio is 18.76, and the P/B ratio is 2.16. Return on equity is 11.5%. These figures are computed in-house from official filings and are reference information only.

Elevance Health — frequently asked questions

What is the P/E ratio of Elevance Health (ELV)?
On a trailing-twelve-month basis, ELV trades at a P/E ratio of 18.76. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Elevance Health?
ELV has a market capitalization of about $96.4B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.